earnings
confidence high
sentiment positive
materiality 0.65
INBS preliminary Q2 revenue $0.61M; six-month gross profit up 32.6% to $0.57M, margin 38.5%
INTELLIGENT BIO SOLUTIONS INC.
2025-Q2 EPS reported
-$1.18
revenue$1,739,549
- Unaudited revenue $0.61M for Q2, $1.48M for six months ended Dec 31, 2024.
- Gross profit for six months increased 32.6% to $0.57M; gross margin expanded to 38.5% from 27.7%.
- Higher-margin cartridge sales driving profitability; 400+ active accounts.
- FDA 510(k) submitted for fingerprint drug screening system to enter U.S. market in 2025.
- Calendar 2024 revenue grew 23% year-on-year; expects to file 10-Q in week of Feb 10.